000 | 01527 a2200373 4500 | ||
---|---|---|---|
005 | 20250511202144.0 | ||
264 | 0 | _c19920630 | |
008 | 199206s 0 0 eng d | ||
022 | _a0091-3057 | ||
024 | 7 |
_a10.1016/0091-3057(91)90106-c _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJohnson, M P | |
245 | 0 | 0 |
_aSerotonin neurotoxicity in rats after combined treatment with a dopaminergic agent followed by a nonneurotoxic 3,4-methylenedioxymethamphetamine (MDMA) analogue. _h[electronic resource] |
260 |
_bPharmacology, biochemistry, and behavior _cDec 1991 |
||
300 |
_a915-22 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_a3,4-Dihydroxyphenylacetic Acid _xmetabolism |
650 | 0 | 4 |
_a3,4-Methylenedioxyamphetamine _xadministration & dosage |
650 | 0 | 4 |
_aAmphetamine _xadministration & dosage |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBrain _xdrug effects |
650 | 0 | 4 |
_aDopamine _xmetabolism |
650 | 0 | 4 |
_aDopamine Agents _xadministration & dosage |
650 | 0 | 4 |
_aHomovanillic Acid _xmetabolism |
650 | 0 | 4 |
_aHydroxyindoleacetic Acid _xmetabolism |
650 | 0 | 4 |
_aIndans _xadministration & dosage |
650 | 0 | 4 | _aN-Methyl-3,4-methylenedioxyamphetamine |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aSerotonin _xmetabolism |
700 | 1 | _aHuang, X M | |
700 | 1 | _aNichols, D E | |
773 | 0 |
_tPharmacology, biochemistry, and behavior _gvol. 40 _gno. 4 _gp. 915-22 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/0091-3057(91)90106-c _zAvailable from publisher's website |
999 |
_c1732587 _d1732587 |